newsfilter
← Latest News
GlobeNewswire·

Celyad Oncology announces receipt of Nasdaq delisting notice

MONT-SAINT-GUIBERT, Belgium, May 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology ((Euronext &, NASDAQ:CYAD) (the "Company"), is a biotechnology company focused on innovative technologies for chimeric antigen receptor